Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: focusing on the Japan criteria

被引：0
|
作者：
Yoshiya, S. [1 ]
Harada, N. [1 ]
Toshima, T. [1 ]
Toshida, K. [1 ]
Kosai-Fujimoto, Y. [1 ]
Tomino, T. [1 ]
Nagao, Y. [1 ]
Kayashima, H. [1 ]
Itoh, S. [1 ]
Yoshizumi, T. [1 ]
机构：
[1] Kyushu Univ, Dept Surg & Sci, Fukuoka, Japan
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
EP-439
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [1] Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria
    Shohei Yoshiya
    Noboru Harada
    Takeo Toshima
    Katsuya Toshida
    Yukiko Kosai
    Takahiro Tomino
    Yoshihiro Nagao
    Hiroto Kayashima
    Shinji Itoh
    Tomoharu Yoshizumi
    Surgery Today, 2024, 54 : 64 - 72
  • [2] Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria
    Yoshiya, Shohei
    Harada, Noboru
    Toshima, Takeo
    Toshida, Katsuya
    Kosai, Yukiko
    Tomino, Takahiro
    Nagao, Yoshihiro
    Kayashima, Hiroto
    Itoh, Shinji
    Yoshizumi, Tomoharu
    SURGERY TODAY, 2024, 54 (01) : 64 - 72
  • [3] Treatment of hepatocellular carcinoma in the transplant era
    Gala-Lopez, Boris
    Gomez-Gutierrez, Manuel
    Fernandez-Selles, Carlos
    Arnal-Monreal, Francisco
    Antonio Copo-Jorge, Jose
    Gonzalez-Castillo, Fernando
    CIRUGIA Y CIRUJANOS, 2010, 78 (05): : 410 - 417
  • [4] HEPATOCELLULAR CARCINOMA: PRESENT TREATMENT STRATEGY IN JAPAN
    Furuse, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 63 - 63
  • [5] Recurrence Pattern and Prognosis after Liver Transplant for Hepatocellular Carcinoma in the MELD Era
    Uchida, K.
    Levi, D.
    Nishida, S.
    Selvaggi, G.
    Tekin, A.
    Taizo, H.
    Garcia, M.
    Feun, L.
    Tzakis, A. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 199 - 200
  • [6] Hepatocellular Carcinoma Recurrence Among Liver Transplant Recipients Within the Milan Criteria
    Felga, G.
    Evangelista, A. S.
    Salvalaggio, P. R.
    Curvelo, L. A.
    Della Guardia, B.
    Almeida, M. D.
    Afonso, R. C.
    Ferraz-Neto, B. H.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (08) : 2459 - 2461
  • [7] Hepatocellular Carcinoma-Recurrence Risk Index May Predict Post-Transplant Hepatocellular Carcinoma Recurrence Better Than Milan Criteria
    Sharma, Pratima
    Byrne, Thomas
    Welch, Kathy
    Amir, Yosephy
    Vargas, Hugo
    Marrero, Jorge
    Merion, Robert
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 451 - 451
  • [8] Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
    Kang, Seong Hee
    Cho, Hyeki
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    Yoon, Jung-Hwan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (45)
  • [9] Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era
    Pfiffer, Tulio E. F.
    Seehofer, Daniel
    Nicolaou, Annett
    Neuhaus, Ruth
    Riess, Hanno
    Trappe, Ralf U.
    TUMORI JOURNAL, 2011, 97 (04): : 436 - 441
  • [10] Changes in Liver Transplant Criteria for Hepatocellular Carcinoma
    Dekey Lhewa
    Neehar D. Parikh
    Current Hepatology Reports, 2017, 16 (1) : 33 - 38
12345